Angeles Alvarez Secord, MD

Articles

Dr. Secord on the Design of the OReO Trial in Ovarian Cancer

October 19th 2021

Angeles A. Secord, MD, discusses the design of the phase 3b OReO trial in ovarian cancer.

Dr. Secord on Treatment Considerations in Platinum-Sensitive Ovarian Cancer

October 7th 2021

Angeles A. Secord, MD, discusses the individual therapeutic preferences and treatment considerations for patients with platinum-sensitive ovarian cancer.

Dr. Secord on Treating Patients with Platinum Sensitive Ovarian Cancer

October 1st 2021

Angeles A. Secord, MD, discusses treating patients with platinum-sensitive ovarian cancer.

Dr. Secord on Frontline Maintenance Therapy in Ovarian Cancer

March 13th 2020

Angeles Alvarez Secord, MD, discusses key takeaways from clinical trials that have evaluated frontline maintenance strategies in patients with advanced ovarian cancer.

Dr. Secord on Financial Toxicity Associated With PARP Inhibition

February 10th 2020

Angeles Alvarez Secord, MD, discusses a presentation from the 2020 SGO Winter Meeting that focused on assistance with the financial burden associated with PARP inhibitors in patients with ovarian cancer.

Dr. Secord on the Role of PARP Inhibitors in Ovarian Cancer

February 9th 2020

Angeles Alvarez Secord, MD, gynecologic oncologist, Duke Cancer Center, discusses the role of PARP inhibitors in ovarian cancer based on their current indications in the treatment landscape.

Dr. Secord on Personalized Treatment in Ovarian Cancer

September 15th 2018

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the growing potential for personalized treatment in ovarian cancer.

Dr. Secord on the Management of Patients With Sarcoma

August 28th 2018

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the management of patients with sarcoma.

Dr. Secord on Using Biomarkers to Guide Treatment Decisions in Ovarian Cancer

August 21st 2018

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the use of biomarkers to guide treatment decisions in patients with ovarian cancer.

Dr. Secord on Determining the Management Strategy for Ovarian Cancer

April 6th 2018

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses determining the management strategy for patients with ovarian cancer.

Dr. Secord on Understanding Patient Preferences

April 10th 2015

Angeles Alvarez Secord, MD, gynecologic cancers specialist, Duke Cancer Center, discusses the importance of understanding patient preferences regarding treatment regimens.